These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 38139462)

  • 1. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma.
    Trejo-Solis C; Silva-Adaya D; Serrano-García N; Magaña-Maldonado R; Jimenez-Farfan D; Ferreira-Guerrero E; Cruz-Salgado A; Castillo-Rodriguez RA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic dysregulation of tricarboxylic acid cycle and oxidative phosphorylation in glioblastoma.
    Trejo-Solís C; Serrano-García N; Castillo-Rodríguez RA; Robledo-Cadena DX; Jimenez-Farfan D; Marín-Hernández Á; Silva-Adaya D; Rodríguez-Pérez CE; Gallardo-Pérez JC
    Rev Neurosci; 2024 Oct; 35(7):813-838. PubMed ID: 38841811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
    Li C; Zhang G; Zhao L; Ma Z; Chen H
    World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamine Addiction In Gliomas.
    Márquez J; Alonso FJ; Matés JM; Segura JA; Martín-Rufián M; Campos-Sandoval JA
    Neurochem Res; 2017 Jun; 42(6):1735-1746. PubMed ID: 28281102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Reprogramming in Glioblastoma Multiforme: A Review of Pathways and Therapeutic Targets.
    Cortes Ballen AI; Amosu M; Ravinder S; Chan J; Derin E; Slika H; Tyler B
    Cells; 2024 Sep; 13(18):. PubMed ID: 39329757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma.
    Yang S; Zhao J; Cui X; Zhan Q; Yi K; Wang Q; Xiao M; Tan Y; Hong B; Fang C; Kang C
    Theranostics; 2022; 12(16):7032-7050. PubMed ID: 36276638
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells.
    Chiasserini D; Davidescu M; Orvietani PL; Susta F; Macchioni L; Petricciuolo M; Castigli E; Roberti R; Binaglia L; Corazzi L
    J Proteomics; 2017 Jan; 152():329-338. PubMed ID: 27890797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma cells require one-carbon metabolism to survive glutamine starvation.
    Tanaka K; Sasayama T; Nagashima H; Irino Y; Takahashi M; Izumi Y; Uno T; Satoh N; Kitta A; Kyotani K; Fujita Y; Hashiguchi M; Nakai T; Kohta M; Uozumi Y; Shinohara M; Hosoda K; Bamba T; Kohmura E
    Acta Neuropathol Commun; 2021 Jan; 9(1):16. PubMed ID: 33468252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.
    Mala U; Baral TK; Somasundaram K
    BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma.
    Clark PM; Mai WX; Cloughesy TF; Nathanson DA
    Curr Neurol Neurosci Rep; 2016 Feb; 16(2):17. PubMed ID: 26759318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Reprogramming in Glioma.
    Strickland M; Stoll EA
    Front Cell Dev Biol; 2017; 5():43. PubMed ID: 28491867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.
    DeBerardinis RJ; Mancuso A; Daikhin E; Nissim I; Yudkoff M; Wehrli S; Thompson CB
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19345-50. PubMed ID: 18032601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas.
    Hujber Z; Horváth G; Petővári G; Krencz I; Dankó T; Mészáros K; Rajnai H; Szoboszlai N; Leenders WPJ; Jeney A; Tretter L; Sebestyén A
    J Exp Clin Cancer Res; 2018 Nov; 37(1):271. PubMed ID: 30404651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
    Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
    Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma.
    Yang R; Li X; Wu Y; Zhang G; Liu X; Li Y; Bao Y; Yang W; Cui H
    Oncogene; 2020 Apr; 39(14):2975-2986. PubMed ID: 32034306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy.
    Wang G; Wang J; Zhao H; Wang J; Tony To SS
    Arch Biochem Biophys; 2015 Aug; 580():84-92. PubMed ID: 26151775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
    Mao H; Lebrun DG; Yang J; Zhu VF; Li M
    Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.
    Kathagen-Buhmann A; Schulte A; Weller J; Holz M; Herold-Mende C; Glass R; Lamszus K
    Neuro Oncol; 2016 Sep; 18(9):1219-29. PubMed ID: 26917237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.
    Alfardus H; McIntyre A; Smith S
    Biomed Res Int; 2017; 2017():9157370. PubMed ID: 28804724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.